Table 3.

Mean total scores for pre-rotation and post-rotation tests (scores are expressed as a total score out of 100)

	Control group			Intervention group
	Pre-rotation	Post-rotation	P-value	Pre-rotation	Post-rotation	P-value
Total score	62.2	68.2	.023 *	60.9	82.6	< .001*
By type of patient encounter:
Initial consultation	59.8	70.1	.023*	58.6	81.6	< .001*
Follow-up care	65.2	66.3	.717	63.6	83.6	< .001*
Diagnosis	53.2	67.1	.015*	50.7	83.6	< .001*
Initiating therapy	64.9	72.5	.072	64.4	80.1	.001*
Natural history	52.2	71.2	.094	49.6	87.0	< .001*
Managing treatment	60.4	52.3	.116	54.9	74.9	.003*
Pregnancy	63.4	63.8	.944	63.5	85.5	.001*
Practice management	73.6	82.8	.072	71.2	80.4	.039*
All COCOS cases†:	66.5	70.4	.152	61.5	80.1	< .001*
Type 1 diabetes	70.7	79.5	.041*	68.2	85.1	< .001*
Graves disease	68.8	65.3	.537	59.6	76.6	.018*
Hyperprolactinemia	54.7	59.3	.554	50.6	77.2	.001*
All non-COCOS cases††	60.3	65.1	.285	60.3	84.9	<.001*
Type 2 diabetes	58.0	76.3	.019*	61.9	90.5	<.001*
Thyroid nodules	68.2	56.4	.008*	68.6	78.3	.060
Polycystic ovarian syndrome	48.8	56.1	.434	52.4	81.7	<.001*

* Significant p-value (< 0.05), paired t-test

† : cumulative score for questions pertaining to topics for which COCOS cases were written (type 1 Diabetes, Graves disease and Hyperprolactinemia)

††: cumulative score for questions pertaining to topics for which COCOS cases were not written (type 2 Diabetes, thyroid nodules, polycystic ovarian syndrome)